Skip to content

MLEC

Moolec Science SA

NASDAQ · Healthcare · Biotechnology · LU

$1.54
−8.63%
Ask drillr
Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open
$1.62
From 52W high
−91.02%
Volume
28820.00
Market cap
$3.19M
P/E (Fwd)
—
EV/EBITDA
−0.3x
P/E (TTM)
—
RSI (14)
17.6
1D Return
−8.63%
YTD Return
−57.46%
SummaryUpdated Jun 1, 2025

Moolec Science SA (NASDAQ:MLEC) is a Luxembourg-based biotechnology company founded in 2008 that specializes in producing animal proteins in plants through a technology called Molecular Farming. The company went public in March 2021 and operates across the United States, Europe, and South America. Moolec represents a disruptive approach in the alternative protein landscape, leveraging the natural efficiency of crops like soybeans and peas to produce traditionally animal-derived proteins through genetic engineering techniques.

Similar companies

Latest newsMore news →

No recent news for MLEC.